Swindon, United Kingdom

Rosaleen McLaughlin


 

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovations of Rosaleen McLaughlin: A Pioneer in Pharmaceutical Engineering

Introduction

Rosaleen McLaughlin is a notable inventor based in Swindon, GB, whose contributions to the pharmaceutical industry have been recognized through 13 patents. Her innovative work focuses on enhancing the stability and efficiency of pharmaceutical compositions, thereby improving the quality of drug formulations.

Latest Patents

Among her recent patents, Rosaleen has developed groundbreaking methods to minimize agglomeration of drug particle coating material during storage. This innovation is crucial for ensuring that pharmaceutical products maintain their disintegration times, which are vital for their efficacy. Her approach includes using solventless mixing methods to prepare pharmaceutical compositions and optimizing coating and dosing ratios to reduce excess unbound coating material.

Another significant patent involves minimizing aeration of suspensions during in-line mixing. This method details a precise process for creating a pharmaceutical suspension by incorporating a matrix solution and hydrophobic particles. The focus on minimizing aeration ensures the consistency and accuracy of dosed weights in preformed blister packs, which is essential for effective medication delivery.

Career Highlights

Rosaleen McLaughlin's professional journey is marked by her association with Catalent U.K. Swindon Zydis Limited, where she continues to contribute to advancements in pharmaceutical technology. Her expertise in drug formulation and development has led to numerous successful projects, establishing her as a key player in her field.

Collaborations

Throughout her career, Rosaleen has collaborated with talented colleagues such as Jonathon Whitehouse and Simon Andrew Martyn Howes. Their collective efforts have fostered a productive environment for innovation and have resulted in significant advancements in the pharmaceutical industry.

Conclusion

Rosaleen McLaughlin's contributions to pharmaceutical innovations not only exemplify her ingenuity as an inventor but also highlight her commitment to improving drug delivery systems. Her patents and collaborative efforts continue to make a lasting impact on the pharmaceutical industry, paving the way for future advancements in drug formulation and stability.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…